37 studies found for:
" March 04, 2009":" April 03, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Completed |
Determining Characteristics and Behaviors of Adolescent Women Regarding HIV Risk and Microbicide Trial Participation
|
||||
| 22 | Suspended |
Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection
|
||||
| 23 | Completed |
Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults
|
||||
| 24 | Enrolling by invitation |
Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults
|
||||
| 25 |
Completed
Has Results |
Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study
|
||||
| 26 | Active, not recruiting |
Pneumocystis in Pathogenesis of HIV-associated Emphysema
|
||||
| 27 | Completed |
Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection
|
||||
| 28 | Recruiting |
Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center
|
||||
| 29 | Recruiting |
High-Dose Chemotherapy With Transplantation of Gene-Modified Stem Cells for High-Risk AIDS-Related Lymphoma
|
||||
| 30 | Completed |
Raltegravir and Atazanavir Dosing Strategy Study
|
||||
| 31 |
Terminated
Has Results |
Combination Pain Therapy in HIV Neuropathy
|
||||
| 32 | Active, not recruiting |
Maraviroc Immune Recovery Study
|
||||
| 33 | Completed |
Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals
|
||||
| 34 | Active, not recruiting |
Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients
|
||||
| 35 | Unknown † |
Asha HIV Health Promotion Intervention in India
|
||||
| 36 | Completed |
Arginine as an Adjuvant Treatment Against Tuberculosis
|
||||
| 37 | Active, not recruiting |
Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)
|
† Indicates status has not been verified in more than two years
